Inflammatory myopathies

Does the ACR/EULAR Total Improvement Score Reflect How Individuals With Autoimmune Inflammatory Myopathies Feel and Function?

J RheumatolPublished Cohort study

Authors' conclusion

The findings of this cohort study support the use of the TIS in AIM research but also highlight potential limitations in its ability to capture outcomes across the broader AIM spectrum, particularly among older individuals and those with longer disease duration.

Study context

Population
Adult patients with autoimmune inflammatory myopathies (AIM) and active disease at baseline who completed a 1-year follow-up visit, from a research cohort
Participants
65 patients
Outcome
Absolute change in PRO scores (pain NRS, FACIT-Fatigue, Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue 8a, Patient Health Questionnaire (PHQ-9), SF-36 PCS and MCS) per 20-unit increase in absolute TIS
Follow-up
1 year
Methodological detailsmultivariable linear regression
  • Multivariable linear regression

Main finding

As reported in the abstract

Association of TIS with PRO changes (adjusted)
  • Increase in absolute Total Improvement Score (TIS) associated with statistically significant improvements in pain, PROMIS-Fatigue, FACIT-Fatigue and SF-36 PCS scores

Observational data: associations, not effects.

Further findings

TIS improvement category · 1 year

No improvement
40%
Minimal improvement
34%
Moderate improvement
26%

FACIT-Fatigue: interaction between age and TIS

Significant interaction between age and TIS

Stratified by disease duration

Only patients with shorter disease duration significantly improved in pain and FACIT-Fatigue scores

Original publication

Does the ACR/EULAR Total Improvement Score Reflect How Individuals With Autoimmune Inflammatory Myopathies Feel and Function? J Rheumatol. Published 15 June 2026. doi:10.3899/jrheum.2026-0046

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.